Home > products > custom-nanocomposites
> fluorescent-labeled-nanocomposites
> dopg-dopc-chol-20-50-30-molar-ratio-based-fluoroliposome-dii
DOPG:DOPC:Chol(20:50:30 molar ratio)-based Fluoroliposome DiI
1,2-dioleoyl-sn-glycero-3-phospho-(1-rac-glycerol) (sodium salt):1,2-dioleoyl-sn-glycero-3-phosphocholine:Cholesterol(20:50:30 molar ratio)-based Fluoroliposome DiI
Product description
DOPG:DOPC:Chol(20:50:30 molar ratio)-based Fluoroliposome DiI can be used in various applications like tracking cellular interactions, uptake studies, and mechanism research in both in vitro and in vivo settings.These modified liposomes can encapsulate therapeutics and enhance their delivery to target sites.
| Appearance | N/A |
|---|---|
| DOPG | 20 molar ratio |
| DOPC | 50 molar ratio |
| Chol | 30 molar ratio |
| DiI-Excitation/Emission | 549/565 |
| Liposome Size | 100 nm |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of dopg-dopc-chol-20-50-30-molar-ratio-based-fluoroliposome-dii
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


